These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10551018)

  • 21. The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings.
    Frölich L
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1003-13. PubMed ID: 12111437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
    Grünberger J; Linzmayer L; Walter H; Rainer M; Masching A; Pezawas L; Saletu-Zyhlarz G; Stöhr H; Grünberger M
    Neuropsychobiology; 1999; 40(1):40-6. PubMed ID: 10420100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
    Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited.
    Ladner CJ; Lee JM
    J Neuropathol Exp Neurol; 1998 Aug; 57(8):719-31. PubMed ID: 9720487
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuronal aging and its implications in human neurological pathology.
    World Health Organ Tech Rep Ser; 1981; 665():1-85. PubMed ID: 6795834
    [No Abstract]   [Full Text] [Related]  

  • 26. [Alzheimer's disease].
    Krankenpfl J; 1999 Oct; 37(10):385-7. PubMed ID: 10693452
    [No Abstract]   [Full Text] [Related]  

  • 27. Acetylcholine, aging, and Alzheimer's disease.
    Muir JL
    Pharmacol Biochem Behav; 1997 Apr; 56(4):687-96. PubMed ID: 9130295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholine and Alzheimer's disease.
    Perry E
    Br J Psychiatry; 1988 Jun; 152():737-40. PubMed ID: 3048527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention.
    Muir JL; Page KJ; Sirinathsinghji DJ; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Nov; 57(2):123-31. PubMed ID: 7509608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cholinergic system, circadian rhythmicity, and time memory.
    Hut RA; Van der Zee EA
    Behav Brain Res; 2011 Aug; 221(2):466-80. PubMed ID: 21115064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease.
    Xuereb JH; Perry EK; Candy JM; Bonham JR; Perry RH; Marshall E
    J Neurol Sci; 1990 Nov; 99(2-3):185-97. PubMed ID: 1964958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic controversies.
    Sarter M; Bruno JP; Dudchenko P
    Trends Neurosci; 1991 Nov; 14(11):484; author reply 485-6. PubMed ID: 1726764
    [No Abstract]   [Full Text] [Related]  

  • 33. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease.
    Rattray M
    Biol Psychiatry; 2001 Feb; 49(3):185-93. PubMed ID: 11230869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological findings in Alzheimer's disease and normal aging.
    Galasko D; Kwo-on-Yuen PF; Klauber MR; Thal LJ
    Arch Neurol; 1990 Jun; 47(6):625-7. PubMed ID: 2346387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A primate model of Alzheimer's disease.
    Wenk GL
    Behav Brain Res; 1993 Nov; 57(2):117-22. PubMed ID: 8117419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can activity modulate the susceptibility of neurons to degeneration?
    Sofroniew MV
    Neurobiol Aging; 1991; 12(4):351-2; discussion 352-5. PubMed ID: 1961371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
    Lemière J; Van Gool D; Dom R
    Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.
    Mufson EJ; Counts SE; Perez SE; Binder L
    Neuropeptides; 2005 Jun; 39(3):233-7. PubMed ID: 15893372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of the basal forebrain cholinergic dysfunction in pathogenesis of declarative memory disorder in Alzheimer's disease].
    Mukhin VN
    Ross Fiziol Zh Im I M Sechenova; 2013 Jun; 99(6):674-81. PubMed ID: 24459876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
    Schliebs R; Arendt T
    J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.